Intranasal Therapeutics
Latest round
- Series B
Last raised
- Feb 2009
Total raised
- $64M
Investors
- 8
About Intranasal Therapeutics
Intranasal Therapeutics Inc.Intranasal Therapeutics Inc. is engaged in the innovative development of therapeutic solutions. The company is headquartered in Saddle Brook, US.Intranasal Therapeutics specializes in innovative therapeutic solutions aimed at a variety of medical conditions. Its primary products include advanced biologics and targeted therapies designed to improve patient outcomes in oncology and autoimmune diseases.Intranasal Therapeutics generates revenue through strategic partnerships and direct sales to healthcare institutions. The company employs a B2B model, collaborating with hospitals and clinics to supply its trademarked biologic products under multi-year contracts. Upcoming new products are designed to address significant gaps in treatment, specifically targeting expansion into North America and Europe by the end of 2010.
Who invested in Intranasal Therapeutics
8 investors across 4 rounds
See all investors in Intranasal Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Intranasal Therapeutics
Who invested in Intranasal Therapeutics?
Intranasal Therapeutics has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intranasal Therapeutics raised?
Intranasal Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Intranasal Therapeutics last raise money?
Intranasal Therapeutics's most recent round on record is a Series B, in Feb 2009.
What does Intranasal Therapeutics do?
Intranasal Therapeutics is a pharmaceuticals company.
Where is Intranasal Therapeutics headquartered?
Intranasal Therapeutics is headquartered in Saddle Brook, US.
Which VCs invest in companies like Intranasal Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Intranasal Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Intranasal Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.